L&C Bio Co. Ltd (290650) — Cash Flow Reinvestment Rate
L&C Bio Co. Ltd (290650) has a Cash Flow Reinvestment Rate of 1.61x as of September 2025, reinvesting ₩6.11 Billion (capex ₩3.10 Billion plus investments ₩-3.01 Billion) from operating cash flow of ₩3.79 Billion. Check L&C Bio Co. Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
L&C Bio Co. Ltd Cash Flow Reinvestment Rate (2017–2021)
Historical reinvestment intensity for L&C Bio Co. Ltd across 5 annual periods. Explore cash flow to debt ratio of L&C Bio Co. Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for L&C Bio Co. Ltd (2017–2021)
Year-by-year capital reinvestment analysis for L&C Bio Co. Ltd. For live market cap and broader valuation context, see 290650 market cap.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 1.51x | ₩16.49 Billion | ₩10.91 Billion | ₩10.25 Billion | ▲ +70.2% |
| 2020 | 0.89x | ₩6.59 Billion | ₩7.42 Billion | ₩3.02 Billion | ▼ -60.7% |
| 2019 | 2.26x | ₩14.53 Billion | ₩6.43 Billion | ₩1.96 Billion | ▼ -45.6% |
| 2018 | 4.15x | ₩15.96 Billion | ₩3.85 Billion | ₩4.74 Billion | ▲ +3954.1% |
| 2017 | 0.10x | ₩390.87 Million | ₩3.82 Billion | ₩285.34 Million | — |